HealthcareJul 17, 2026

Pfizer, Inc.

Company Profile Analysis

Book Demo Subscribe Now

Year Founded & Workforce

1848-12-31

83,000 Employees

Industry

Healthcare

Services

Pfizer, Inc. Overview

Company Headquarters: New York, US

Founded: 1849

Workforce: ~ 83,000

Company Working: Pfizer, Inc. is a well-established company and one of the major players in the global pharmaceuticals market. Pfizer Inc. is a research-based biopharmaceutical firm. The company is involved in the discovering, developing, manufacturing, marketing, sales and distribution of biopharmaceutical products across the globe. It operates through two segments—Pfizer innovative health and Pfizer essential health. The Pfizer innovative health segment focuses on research and development of medicines and vaccines and consumer healthcare products in different therapeutic areas. On the other hand, the Pfizer essential health segment is responsible for the research & development of branded generic products, generic sterile injectable products, biosimilars, and anti-infectives. The health care portfolio of Pfizer includes human and animal biologic and small molecule medicines and vaccines, along with nutritional products and many other consumer products. There are various brands under which the company provides vitamin and mineral supplements. Some of the brands selling vitamin and mineral supplements are Centrum, ProNutrients, Emergen-C, and Caltrate. The company operates through 36 manufacturing facilities throughout the world. Pfizer distributes its products in more than 185 countries across the globe.

Strategy

Pfizer, Inc. aims to maintain the quality and safety standards of its products. It is focused on offering innovative products and, thus, plans to invest heavily in research & development over the next few years. The company emphasizes inorganic as well as organic growth strategies such as investing heavily in R&D, developing and launching new products; expanding its presence in various regions and countries across the world; and acquiring small market players to expand its product portfolio. Moreover, Pfizer focuses on establishing an efficient supply chain, which helps the company in producing and distributing its products efficiently across the globe. This also allows the company to respond immediately to the changing consumer demands, thereby staying competitive in the industry.

Company Snapshot

$41,651M

Revenue

83,000

Employees

1848-12-31

Founded

New York, US

Headquarters

SWOT Analysis

Strengths

Strong brand name & recall globally
Diversified solution portfolio of products and services
Revived blockbuster credentials in recent years
Diversified portfolio of products and services
Revived credentials in recent years
Revived blockbuster credentials in the recent years
Diversified product portfolio
Strong brand name
Large distribution channel
Strong brand name in respective markets
Strong focus on targeted offerings
Strong sales and market strategies
Excellent R&D infrastructure
For more than 174 years, Pfizer has been a leading company in pharmaceutical industry. The company has built a solid and reputable brand over the period. The long-standing history of the company and its commitment to quality has earned it high trust among patients, healthcare professionals, and investors.
Pfizer’s dedication towards research and development has allowed the company in maintaining a strong pipeline of innovative drugs and therapies

Weaknesses

Legal complications in patents and drug-testing
Limited penetration of the biologics market
Legal complications in drug-testing
Expiration of patents
Limited penetration in the biologics market
Rely on limited business segments
Relies on limited business segments
Periodic difficulties and delays in manufacturing
Voluntary recalls of a product
Lacking in areas of primary concern such as cardiovascular (CV) & central nervous system (CNS)
Legal complication in patents and drug-testing
Patent expiration of its best seller drugs is the major challenge Pfizer faces. When patents expire, competitors can introduce basic versions of the drugs, significantly reducing revenue for the original product.

Opportunities

Strategic approach by cutting the manufacturing cost
Acquisition and in-licensing development opportunities
Acquisitions and in-licensing development opportunities
Robust market for generic medicines
Reduction of manufacturing cost
Acquisitions and joint ventures with regional distributors
Strategic acquisition activities
Strategic approach by cutting manufacturing cost
Pfizer can continue to expand and grow its product portfolio by doing strategic acquisitions and partnerships. By collaborating or acquiring the other companies, Pfizer can access new technologies, expand its business areas, and make its R&D pipeline stronger.

Threats

Deviations in legal aspects of healthcare
Mergers and acquisitions could further decline Pfizer’s profitability
High government regulation for using cannabinoid as a legal product
M&A activity could further decline Pfizer’s profitability
Strict control of government regulatory agencies
More government regulations for using cannabinoid as a legal product
Major software players entering into healthcare sectors
Mergers & acquisitions could further decline Pfizer’s profitability
Competitive market landscape
Deviations in legal aspects of regulatory policies in healthcare
Price wars
Pharmaceutical industry is highly regulated. Any changes in regulatory requirements or increased scrutiny affects the approval, development, and marketing of the products.

Key Developments

Date	Approach	Development
June 2017	Partnership	Pfizer started to construct a new facility for research and development at Chesterfield, Missouri, US.
November 2018	Approval	Pfizer received FDA approval for Daurismo for the treatment of acute myeloid leukemia.
July 2019	Acquisition	Pfizer acquired Array BioPharma Inc., a US-based company. This acquisition has strengthened Pfizer’s biopharmaceutical and oncology business.
July 2019	Acquisition	Pfizer acquired Therachon Holding AG, a clinical-stage biotechnology company. This acquisition has helped Pfizer to strengthen its clinical, biotechnology, other related businesses.
August 2019	Joint Venture	Pfizer and GlaxoSmithKline entered into a joint venture to create a premier global consumer healthcare company, in which Pfizer owns a 32% equity stake, and GSK owns 68%. Under the agreement, it announced a merger of its consumer health business unit with GlaxoSmithKline, expanding its supplement and over-the-counter product portfolio.
September 2022	Expansion	Centrum expanded its presence and entered in India Market. The company launched Centrum Multivitamin range for its entry in the Indian market. This multivitamin range is for recognising the difference in nutritional requirements by gender and age in India. It offers 4 multivitamin variants shaped for meeting the new age nutrition needs of various consumers. The multivitamin range includes Centrum Men, Centrum Women, Centrum Kids, and Centrum Adults 50+.
August 2019	Joint Venture	Pfizer closed a deal of joint venture with GlaxoSmithKline. This joint venture helped the company in combining their brand product portfolio and provided with leadership positions in pain relief, respiratory and vitamins, minerals and supplements, and therapeutic oral health.

Product Offering

Pfizer, Inc.
- Key Products
- Allogenic CAR-T Candidate
- CD22 Directed Antibody-Drug Conjugate
- Heart Failure
- Chemotherapy
- Eye Health Supplements
- Meningitis
- Pemphigus Vulgaris
- PEGylated Drugs
- Nutricosmetics
- Internal Medicine
- Anti-hypertensive drugs
- Vitamin & Mineral Supplements Market

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Pfizer, Inc. as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Pfizer, Inc.

Company Headquarters: New York, US Founded: 1849 Workforce: ~ 83,000 Company Working: Pfizer, Inc. is a well-established company and one of the major players in the global pharmaceuticals market. Pfizer Inc. is a research-based biopharmaceutical firm. The company is involved in the discovering, developing, manufacturing, marketing, sales and distribution of biopharmaceutical products across the globe. It operates through two segments—Pfizer innovative health and Pfizer essential health. The Pfizer innovative health segment focuses on research and development of medicines and vaccines and consumer healthcare products in different therapeutic areas. On the other hand, the Pfizer essential health segment is responsible for the research & development of branded generic products, generic sterile injectable products, biosimilars, and anti-infectives. The health care portfolio of Pfizer includes human and animal biologic and small molecule medicines and vaccines, along with nutritional products and many other consumer products. There are various brands under which the company provides vitamin and mineral supplements. Some of the brands selling vitamin and mineral supplements are Centrum, ProNutrients, Emergen-C, and Caltrate. The company operates through 36 manufacturing facilities throughout the world. Pfizer distributes its products in more than 185 countries across the globe.

Starting from

$4,950